Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 17

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 3
Chunk 17
---
 and potential partners by competitors could result in a decrease in the number of
EUDA’s current and potential clients, as partners may no longer facilitate the adoption of EUDA’s services to potential clients.

If
EUDA is unsuccessful in establishing or maintaining relationships with third parties, the Company’s ability to compete in the
marketplace or to grow the Company’s revenue could be impaired and the results of operations may suffer. Even if the Company
is successful, it cannot assure investors that these relationships will result in increased client use of its products and services
offerings or increased revenue. While EUDA expects that these relationships will continue, it cannot guarantee that they will. Any
material changes in government regulations, or the loss of these affiliations, could impair the Company’s ability to provide
services to members and clients and could have a material adverse effect on the Company’s business, financial condition and
results of operations.

  10  

If
EUDA is not able to develop new competitive and market relevant services that are adopted by clients, or if EUDA fails to provide high quality support services required by its clients, EUDA’s growth prospects, revenues and operating results could
be materially and adversely affected.

EUDA’s
longer-term operating results and revenue growth will depend in part on its ability to successfully develop and sell new services
that existing and potentially new clients want and are willing to purchase. EUDA needs to continuously invest significant resources
to enhance existing, and introduce new services, and provide high-quality support services to clients and prospective clients.
If EUDA is unable to predict or adapt to changes in user preferences or industry or regulatory changes, or if the Company is unable
to add on or modify its services on a timely basis in response to those changes, clients may not purchase from EUDA, and
EUDA’s services may be perceived as less competitive or somewhat obsolete. If EUDA’s products and services offerings are
not responsive to the needs of clients, are not appropriately timed with market opportunity, or are not effectively brought to
market, it could have a material adverse impact on operating results. EUDA’s success also depends on successfully providing
high-quality support services to resolve any issues related to EUDA’s services, as they are important for the successful
marketing and sale of services and for the renewal of existing clients. If EUDA fails to provide the appropriate after-sales service, including follow-up with clients after their cell therapies
to ensure proper post-treatment support and care, the Company’s ability to sell